Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
3243
-
Total 13F shares, excl. options
-
1.24B
-
Shares change
-
+34.7M
-
Total reported value, excl. options
-
$192B
-
Value change
-
+$5.4B
-
Put/Call ratio
-
0.55
-
Number of buys
-
1273
-
Number of sells
-
-1493
-
Price
-
$154.97
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q4 2023
3,478 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q4 2023.
AbbVie Inc. - Common Stock (ABBV) has 3,243 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.24B shares
of 1.77B outstanding shares and own 70.07% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (160M shares), BlackRock Inc. (143M shares), STATE STREET CORP (78.2M shares), JPMORGAN CHASE & CO (52M shares), Capital International Investors (45M shares), GEODE CAPITAL MANAGEMENT, LLC (37M shares), MORGAN STANLEY (34.1M shares), Capital Research Global Investors (30.3M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (24.5M shares), and Bank of New York Mellon Corp (22.1M shares).
This table shows the top 3243 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.